In addition, GE can block Sphk1/S1P/S1PR1 pathway hyperactivation, inhibit the abnormal proliferation, invasion and migration of RASFs (Sun et al., 2020), and hence it plays a crucial role in the treatment of RA. This evidence concerns the gene S1PR1 and rheumatoid arthritis.